StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)

Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –

biote price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

biote's price to sales ratio was 0.2× on Nov 11, 2026, against 0.5× a year earlier. Over the last 4 years it ranged from 0.2× to 2.3×, with a median of 0.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.3
2025Dec 31, 20250.5×−0.6
2024Dec 31, 20241.1×+0.5
2023Dec 29, 20230.5×−0.8
2022Dec 30, 20221.3×–

More biote figures

See a number that looks wrong?